Skip to main content

Table 1 Clinical characteristics of patient cohort

From: Early circulating tumour DNA kinetics measured by ultra-deep next-generation sequencing during radical radiotherapy for non-small cell lung cancer: a feasibility study

Patient Age ECOG PS Co-morbidities Tobacco T-stage N-stage M-stage Histology EGFR ALK PD-L1
1 82 1 sciatica Ex (60 PYH) 2a 2 0 adenocarcinoma unk unk unk
2 68 1 TIA, hypothyroidism, dyslipidaemia, MS Ex (unk) 2a 1 0 squamous cell N/A N/A 1–49%
3 83 1 macular degeneration, BPH, dyslipidaemia, HTN Ex (unk) 4 2 0 adenosquamous unk unk unk
4 61 2 MI, Raynaud’s Active 3 2 0 squamous cell N/A N/A < 1%
5 69 0 N/A Ex (unk) 3 1 0 adenocarcinoma WT WT > 50%
  1. (ECOG PS Eastern Cooperative Oncology Group Performance Status, PYH pack year history, unk unknown, WT wild-type, TIA transient ischaemic attack, MS multiple sclerosis, HTN hypertension, BPH benign prostatic hyperplasia, MI myocardial infarction, N/A not applicable)